Deutsches Register www.Covid19-Rheuma.de: Statusbericht nach 1 Jahr der Pandemie

Hasseli, Rebecca; Pfeil, Alexander; Hoyer, Bimba Franziska; Lorenz, Hanns-Martin; Regierer, Anne C.; Richter, Jutta G.; Schmeiser, Tim; Strangfeld, Anja; Voll, Reinhard E.; Krause, Andreas; Schulze-Koops, Hendrik; Müller-Ladner, Ulf; Specker, Christof

The COVID-19 registry (www.covid19-rheuma.de) of the German Society of Rheumatology was the first registry for the acquisition and systemic evaluation of viral infections in patients with inflammatory rheumatic diseases (IRD). This has enabled rapid generation of scientific data that will help to improve the care of patients with IRD in the context of the pandemic. In addition to confirming general risk factors, such as patient age and comorbidities (e.g. cardiovascular, chronic lung and kidney diseases), the use of glucocorticoids and the disease activity of the rheumatic disease could be identified as disease-specific independent risk factors for the need of hospitalization due to COVID-19. Evaluations of the continuously growing cohort of patients with IRD and COVID-19 enable recommendations for patient care to be based on better evidence. Cooperation with international rheumatology registries (e.g. European COVID-19 registry for IRD) enables analyses of aggregated cohorts of patients with IRD and COVID-19 for international comparisons and statistically even more reliable statements.